ORIC Pharmaceuticals, Inc.
ORICNASDAQ NMS - GLOBAL MARKETCountry unavailableReal-Time Price
$8.82USD
+0.33 (+3.89%)Today
$8.80-0.02 (-0.23%)Pre-MarketLast quote · Nov 6, 2026, 4:23 AM ET · Updates paused
ORIC Pharmaceuticals, Inc. (ORIC) Stock Analysis
BTI's proprietary analysis of ORIC Pharmaceuticals, Inc. (ORIC): overall score, long- and short-term outlook, risk rating and fair-value verdict based on fundamentals, valuation and momentum.
Major-Firm Consensus
Strong Buy
Filtered to 22 major global investment banks
Buy
20
Hold
2
Sell
0
Price Target Consensus
High
$27.00
Consensus
$21.71
Low
$14.00
Current
$8.82
Upside: +146.1%
Target Trend
Last Month— (0)
Last Quarter— (0)
Last Year— (0)
Ratings History — Major Investment Banks
| Firm | Rating | Action | Previous | Price Target | Upside | Date |
|---|---|---|---|---|---|---|
| Stifel Nicolaus | Buy | Maintains | — | $18.00 | +104.1% | Oct 30, 2026 |
| Wedbush | Buy | Maintains | — | — | — | Oct 27, 2026 |
| JonesTrading | Buy | Reiterates | — | $25.00 | +183.4% | Oct 27, 2026 |
| Cantor Fitzgerald | Buy | Maintains | — | — | — | Oct 27, 2026 |
| H.C. Wainwright | Buy | Reiterates | — | $27.00 | +206.1% | Oct 27, 2026 |
| BTIG | Buy | Maintains | — | $26.00 | +194.8% | Oct 26, 2026 |
| Guggenheim | Buy | Initiates | — | $18.00 | +104.1% | Oct 22, 2026 |
| Wells Fargo | Buy | Maintains | — | $25.00 | +183.4% | Oct 16, 2026 |
Want deeper AI-powered analysis?
Get BTI AI's full investment thesis, valuation models, and risk assessment for ORIC.